| Safety and efficacy of NVX-CoV2373 Covid-19 vaccine PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... New England Journal of Medicine 385 (13), 1172-1183, 2021 | 948 | 2021 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 661 | 2021 |
| Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial RC Fitzgerald, M di Pietro, M O'Donovan, R Maroni, B Muldrew, ... The Lancet 396 (10247), 333-344, 2020 | 181 | 2020 |
| Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer … S Toback, E Galiza, C Cosgrove, J Galloway, AL Goodman, PA Swift, ... The Lancet Respiratory Medicine 10 (2), 167-179, 2022 | 133 | 2022 |
| Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases 22 (8), 1131-1141, 2022 | 131 | 2022 |
| The prevalence of vitamin D deficiency and the determinants of 25 (OH) D concentration in older Irish adults: data from The Irish Longitudinal Study on Ageing (TILDA) E Laird, AM O’Halloran, D Carey, M Healy, D O’Connor, P Moore, ... The Journals of Gerontology: Series A 73 (4), 519-525, 2018 | 119 | 2018 |
| Financial stress and depression in adults: A systematic review N Guan, A Guariglia, P Moore, F Xu, H Al-Janabi PloS one 17 (2), e0264041, 2022 | 110 | 2022 |
| Injurious falls and syncope in older community-dwelling adults meeting inclusion criteria for SPRINT DJ Sexton, M Canney, MDL O’Connell, P Moore, MA Little, ... JAMA internal medicine 177 (9), 1385-1387, 2017 | 68 | 2017 |
| Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of … X Liu, APS Munro, S Feng, L Janani, PK Aley, G Babbage, D Baxter, ... Journal of Infection 84 (6), 795-813, 2022 | 59 | 2022 |
| Counting the time lived, the time left or illness? Age, proximity to death, morbidity and prescribing expenditures PV Moore, K Bennett, C Normand Social Science and Medicine 184 (July), 1-14, 2017 | 41 | 2017 |
| Polypharmacy in adults over 50 in Ireland: opportunities for cost saving and improved healthcare K Richardson, P Moore, J Peklar, R Galvin, K Bennett, RA Kenny | 37 | 2012 |
| Personality and preventive healthcare utilisation: Evidence from the Irish Longitudinal Study on Ageing A Nolan, C McCrory, P Moore Preventive Medicine 120, 107-112, 2019 | 36 | 2019 |
| Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... Clinical Infectious Diseases 76 (3), 398-407, 2023 | 32 | 2023 |
| Efficacy of the NVX-CoV2373 Covid-19 vaccine against the B. 1.1. 7 variant PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... MedRxiv, 2021.05. 13.21256639, 2021 | 22 | 2021 |
| Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial IT Lee, CA Cosgrove, P Moore, C Bethune, R Nally, M Bula, PA Kalra, ... The Lancet Infectious Diseases 23 (9), 1007-1019, 2023 | 15 | 2023 |
| Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3 … G de Bruyn, J Wang, A Purvis, MS Ruiz, H Adhikarla, S Alvi, MI Bonaparte, ... EclinicalMedicine 62, 2023 | 15 | 2023 |
| Did government spending cuts to social care for older people lead to an increase in emergency hospital admissions? An ecological study, England 2005–2016 P Seamer, S Brake, P Moore, MA Mohammed, S Wyatt BMJ open 9 (4), e024577, 2019 | 13 | 2019 |
| Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial X Liu, APS Munro, A Wright, S Feng, L Janani, PK Aley, G Babbage, ... Journal of Infection 87 (1), 18-26, 2023 | 11 | 2023 |
| The Importance of Proximity to Death in Modelling Community Medication Expenditures for Older People: Evidence From New Zealand PV Moore, K Bennett, C Normand Applied Health Economics and Health Policy 12 (6), 623 - 633, 2014 | 11 | 2014 |
| Changes in public healthcare entitlement and healthcare utilisation among the older population in Ireland A Nolan, Y Ma, P Moore Dublin: The Irish Longitudinal Study on Ageing, 2016 | 10 | 2016 |
Eamon LairdResearch FellowVerified email at tcd.ie
